{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:43:35Z","timestamp":1790898215873,"version":"4.1.0"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["K\\u03A0-06-H59\/1"],"award-info":[{"award-number":["K\\u03A0-06-H59\/1"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["K\\u03A0-06 H31\/15\/2019"],"award-info":[{"award-number":["K\\u03A0-06 H31\/15\/2019"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["KP-06 N31\/15\/2019"],"award-info":[{"award-number":["KP-06 N31\/15\/2019"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["KP-06-N59\/1"],"award-info":[{"award-number":["KP-06-N59\/1"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.exger.2023.112334","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T23:30:06Z","timestamp":1700868606000},"page":"112334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Old age as a risk factor for liver diseases: Modern therapeutic approaches"],"prefix":"10.1016","volume":"184","author":[{"given":"Milena","family":"Georgieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charilaos","family":"Xenodochidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Krasteva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2023.112334_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0015","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.transproceed.2009.03.080","article-title":"Elderly versus young liver transplant recipients: patient and graft survival","volume":"41","author":"Adani","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.exger.2023.112334_bb0020","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/CIA.S295524","article-title":"NAFLD in the elderly","volume":"16","author":"Alqahtani","year":"2021","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.exger.2023.112334_bb0025","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.3748\/wjg.v13.i46.6150","article-title":"Telbivudine: a new treatment for chronic hepatitis B","volume":"13","author":"Amarapurkar","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb0030","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1053\/j.gastro.2016.12.003","article-title":"Milk fat globule-EGF factor 8, secreted by mesenchymal stem cells, protects against liver fibrosis in mice","volume":"152","author":"An","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exger.2023.112334_bb0035","series-title":"Pentoxifylline","author":"Annamaraju","year":"2022"},{"key":"10.1016\/j.exger.2023.112334_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0045","series-title":"Liver Cirrhosis","article-title":"Regenerative medicine in liver cirrhosis: promises and pitfalls","author":"Asima Tayyeb","year":"2017"},{"key":"10.1016\/j.exger.2023.112334_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010041","article-title":"Nanomedicine in hepatocellular carcinoma: a new frontier in targeted cancer treatment","volume":"14","author":"Bakrania","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exger.2023.112334_bb0055","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/liv.12570","article-title":"The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis","volume":"35","author":"Barreyro","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.exger.2023.112334_bb0060","doi-asserted-by":"crossref","first-page":"14185","DOI":"10.3748\/wjg.v20.i39.14185","article-title":"Nonalcoholic fatty liver disease and aging: epidemiology to management","volume":"20","author":"Bertolotti","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11122236","article-title":"Assessing liver fibrosis using the FIB4 index in the community setting","volume":"11","author":"Blanco-Grau","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.exger.2023.112334_bb0070","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2147\/CIA.S194543","article-title":"Grip strength: an indispensable biomarker for older adults","volume":"14","author":"Bohannon","year":"2019","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.exger.2023.112334_bb0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.redox.2018.01.009","article-title":"Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches","volume":"15","author":"Borrelli","year":"2018","journal-title":"Redox Biol."},{"issue":"22","key":"10.1016\/j.exger.2023.112334_bb0080","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1111\/bph.15853","article-title":"Chronic liver diseases: from development to novel pharmacological therapies: IUPHAR review 37","volume":"180","author":"Borrello","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exger.2023.112334_bb0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13046-022-02297-2","article-title":"Epigenetic remodelling in human hepatocellular carcinoma","volume":"41","author":"Braghini","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.exger.2023.112334_bb0090","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc19-0167","article-title":"Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: a randomized controlled trial","volume":"42","author":"Bril","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exger.2023.112334_bb0095","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/00007611-200295080-00010","article-title":"Hepatitis A epidemic in the elderly","volume":"95","author":"Brown","year":"2002","journal-title":"South. Med. J."},{"key":"10.1016\/j.exger.2023.112334_bb0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/geronj\/31.4.441","article-title":"The stereotype of \u201cold.\u201d A review and alternative approach","volume":"31","author":"Brubaker","year":"1976","journal-title":"J. Gerontol."},{"key":"10.1016\/j.exger.2023.112334_bb0105","series-title":"Infectious Diseases","first-page":"1327","article-title":"155 - drugs to treat viral hepatitis","author":"Burke","year":"2017"},{"key":"10.1016\/j.exger.2023.112334_bb0110","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.exger.2023.112334_bb0115","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/cells11203328","article-title":"mRNA-based approaches to treating liver diseases","volume":"11","author":"Cacicedo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.exger.2023.112334_bb0120","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa1112082","article-title":"Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects","volume":"367","author":"Carlsson","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0125","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3748\/wjg.v27.i16.1691","article-title":"From hepatitis A to E: a critical review of viral hepatitis","volume":"27","author":"Castaneda","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb0130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.exger.2023.112334_bb0135","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2019.11.296","article-title":"Effects of belapectin, an inhibitor of Galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension","volume":"158","author":"Chalasani","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exger.2023.112334_bb0140","article-title":"Insights into the role of PPAR\u03b2\/\u03b4 in NAFLD","volume":"19","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exger.2023.112334_bb0145","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16159-x","article-title":"Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: a randomized controlled trial","volume":"7","author":"Cheng","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exger.2023.112334_bb0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.exger.2023.112334_bb0160","article-title":"Regulating intestinal microbiota in the prevention and treatment of alcohol-related liver disease","volume":"2020","author":"Chi","year":"2020","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0165","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.exger.2023.112334_bb0170","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.21873\/invivo.11618","article-title":"A review of hepatocellular carcinoma in elderly patients focused on management and outcomes","volume":"33","author":"Cho","year":"2019","journal-title":"In Vivo"},{"key":"10.1016\/j.exger.2023.112334_bb0175","article-title":"Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury","volume":"12","author":"Cho","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exger.2023.112334_bb0180","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3350\/cmh.2020.0163","article-title":"The effect of moderate alcohol drinking in nonalcoholic fatty liver disease","volume":"26","author":"Choi","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0185","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exger.2023.112334_bb0190","series-title":"Liver Transplantation","author":"Dababneh","year":"2022"},{"key":"10.1016\/j.exger.2023.112334_bb0195","doi-asserted-by":"crossref","first-page":"735","DOI":"10.21037\/atm-20-5422","article-title":"Exosomes as therapeutic vehicles in liver diseases","volume":"9","author":"Ding","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810972","article-title":"Mesenchymal stem cell-derived exosomes: a promising therapeutic agent for the treatment of liver diseases","volume":"23","author":"Ding","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exger.2023.112334_bb0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2015.03.015","article-title":"Targeting hepatitis B virus cccDNA by CRISPR\/Cas9 nuclease efficiently inhibits viral replication","volume":"118","author":"Dong","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.exger.2023.112334_bb0210","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41366-021-00881-8","article-title":"Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity","volume":"45","author":"Drolz","year":"2021","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.exger.2023.112334_bb0215","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/1087057111417871","article-title":"Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview","volume":"16","author":"Eglen","year":"2011","journal-title":"SLAS Discov."},{"key":"10.1016\/j.exger.2023.112334_bb0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/sctm.19-0107","article-title":"Prenatal stem cell therapy for inherited diseases: past, present, and future treatment strategies","volume":"9","author":"Ekblad-Nordberg","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0225","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.3390\/v7102868","article-title":"Inhibitors of the hepatitis C virus polymerase; mode of action and resistance","volume":"7","author":"Eltahla","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.exger.2023.112334_bb0230","article-title":"Antiviral treatment of hepatitis C","volume":"348","author":"Feeney","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.exger.2023.112334_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263931","article-title":"Lifestyle changes in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"17","author":"Fern\u00e1ndez","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exger.2023.112334_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413219","article-title":"The new therapeutic approaches in the treatment of non-alcoholic fatty liver disease","volume":"22","author":"Filipovic","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exger.2023.112334_bb0245","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1200\/JCO.20.00808","article-title":"Phase Ib study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma","volume":"38","author":"Finn","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.exger.2023.112334_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11216512","article-title":"Cirrhosis, a global and challenging disease","volume":"11","author":"Fortea","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00000658-199002000-00005","article-title":"Hepatic resection in the elderly","volume":"211","author":"Fortner","year":"1990","journal-title":"Ann. Surg."},{"key":"10.1016\/j.exger.2023.112334_bb0260","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40266-018-0553-3","article-title":"Pre-exposure prophylaxis for HIV infection in the older patient: what can be recommended?","volume":"35","author":"Franconi","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.exger.2023.112334_bb0265","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10616-020-00372-0","article-title":"A bioartificial liver device based on three-dimensional culture of genetically engineered hepatoma cells using hollow fibers","volume":"72","author":"Fujii","year":"2020","journal-title":"Cytotechnology"},{"key":"10.1016\/j.exger.2023.112334_bb0270","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jhep.2013.03.020","article-title":"Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C","volume":"59","author":"Furusyo","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0275","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13148-019-0776-0","article-title":"The timeline of epigenetic drug discovery: from reality to dreams","volume":"11","author":"Ganesan","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.exger.2023.112334_bb0280","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/ijms21072427","article-title":"Amination of graphene oxide leads to increased cytotoxicity in hepatocellular carcinoma cells","volume":"21","author":"Georgieva","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exger.2023.112334_bb0285","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/039139889601901105","article-title":"Development of a hybrid liver support system: a review","volume":"19","author":"Gerlach","year":"1996","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.exger.2023.112334_bb0290","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41397-019-0138-5","article-title":"Cancer\u2019s epigenetic drugs: where are they in the cancer medicines?","volume":"20","author":"Ghasemi","year":"2020","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.exger.2023.112334_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11050336","article-title":"Selective targeting of epigenetic readers and histone deacetylases in autoimmune and inflammatory diseases: recent advances and future perspectives","volume":"11","author":"Ghiboub","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0300","first-page":"1627","article-title":"Bariatric surgery in elderly patients: a systematic review","volume":"10","author":"Giordano","year":"2015","journal-title":"Clin. Interv. Aging"},{"issue":"109","key":"10.1016\/j.exger.2023.112334_bb0305","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1152\/japplphysiol.00238.2010","article-title":"Epigenetic alterations in aging","volume":"1985","author":"Gonzalo","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.exger.2023.112334_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00297","article-title":"Gene therapy leaves a vicious cycle","volume":"9","author":"Goswami","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.exger.2023.112334_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111358","article-title":"Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression","volume":"8","author":"Gottlieb","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.exger.2023.112334_bb0320","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-4933-10-9","article-title":"Mast cells and the liver aging process","volume":"10","author":"Grizzi","year":"2013","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.exger.2023.112334_bb0325","first-page":"601","article-title":"Glecaprevir\/pibrentasvir (Mavyret) for the treatment of chronic hepatitis C","volume":"98","author":"Grover","year":"2018","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.exger.2023.112334_bb0330","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S2468-1253(22)00017-6","article-title":"Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2\/3): a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"7","author":"Harrison","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.601349","article-title":"FGF19 and FGF21 for the treatment of NASH-two sides of the same coin? Differential and overlapping effects of FGF19 and FGF21 from mice to human","volume":"11","author":"Henriksson","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exger.2023.112334_bb0340","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/hep.21477","article-title":"Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice","volume":"45","author":"Higashiyama","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.exger.2023.112334_bb0345","first-page":"851","article-title":"Clinical characteristics of hepatocellular carcinoma in elderly patients","volume":"2","author":"Honda","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.exger.2023.112334_bb0350","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13287-023-03370-z","article-title":"Cell therapy in end-stage liver disease: replace and remodel","volume":"14","author":"Hu","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.exger.2023.112334_bb0355","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.kjms.2011.10.020","article-title":"Chronic hepatitis C infection in the elderly","volume":"27","author":"Huang","year":"2011","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.exger.2023.112334_bb0360","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3892\/mmr.2021.11944","article-title":"Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation","volume":"23","author":"Huang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.exger.2023.112334_bb0365","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13287-021-02524-1","article-title":"Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases","volume":"12","author":"Huang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.exger.2023.112334_bb0370","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12876-021-01837-y","article-title":"Sofosbuvir\/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb0375","doi-asserted-by":"crossref","first-page":"12197","DOI":"10.3748\/wjg.v21.i42.12197","article-title":"Hepatocellular carcinoma in the elderly: meta-analysis and systematic literature review","volume":"21","author":"Hung","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb0380","article-title":"Cell-based liver therapies: past, present and future","volume":"373","author":"Iansante","year":"2018","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.exger.2023.112334_bb0385","article-title":"FDA-approved pharmacotherapy for weight loss over the last decade","volume":"14","author":"Idrees","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.exger.2023.112334_bb0390","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3892\/etm.2022.11293","article-title":"Epigenetics in inflammatory liver diseases: a clinical perspective (review)","volume":"23","author":"Isac","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0395","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0042-1750716","article-title":"Acute liver injury due to glecaprevir\/pibrentasvir in a patient with chronic hepatitis C virus infection without cirrhosis","volume":"12","author":"Jain","year":"2022","journal-title":"Avicenna J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2023.112334_bb0400","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jhep.2020.11.042","article-title":"The global burden of cirrhosis: a review of disability-adjusted life-years lost and unmet needs","volume":"75","author":"Jepsen","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0405","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5551\/jat.43372","article-title":"Novel approaches for the treatment of familial hypercholesterolemia: current status and future challenges","volume":"25","author":"Jiang","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.exger.2023.112334_bb0410","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/jcmm.16123","article-title":"Advances on liver cell-derived exosomes in liver diseases","volume":"25","author":"Jiao","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0415","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.cger.2007.06.006","article-title":"Aging liver and hepatitis","volume":"23","author":"Junaidi","year":"2007","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0420","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.exger.2023.112334_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108737","article-title":"GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis","volume":"174","author":"Karagiannis","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.exger.2023.112334_bb0430","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1111\/liv.14659","article-title":"Cellular senescence and hepatitis B-related hepatocellular carcinoma: an intriguing link","volume":"40","author":"Karakousis","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.exger.2023.112334_bb0435","doi-asserted-by":"crossref","first-page":"60","DOI":"10.17925\/EE.2023.19.1.60","article-title":"Resmetirom: an orally administered, small molecule, liver-directed, \u03b2-selective THR agonist for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"19","author":"Karim","year":"2023","journal-title":"touchREV. Endocrinol."},{"key":"10.1016\/j.exger.2023.112334_bb0440","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/idoj.IDOJ_169_17","article-title":"Treatment of dermatophytosis in elderly, children, and pregnant women","volume":"8","author":"Kaul","year":"2017","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.exger.2023.112334_bb0445","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1200\/JCO.20.03555","article-title":"Safety, efficacy, and pharmacodynamics of tremelimumab plus durvalumab for patients with unresectable hepatocellular carcinoma: randomized expansion of a phase I\/II study","volume":"39","author":"Kelley","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.exger.2023.112334_bb0450","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3727\/096368909X484707a","article-title":"Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis","volume":"19","author":"Khan","year":"2010","journal-title":"Cell Transplant."},{"key":"10.1016\/j.exger.2023.112334_bb0455","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8910821","article-title":"Cellular mechanisms of liver regeneration and cell-based therapies of liver diseases","volume":"2017","author":"Kholodenko","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.exger.2023.112334_bb0460","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MOG.0000000000000176","article-title":"Aging and liver disease","volume":"31","author":"Kim","year":"2015","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb0465","series-title":"Principles and Practice of Pediatric Infectious Diseases","first-page":"1583","article-title":"295 - antiviral agents","author":"Kimberlin","year":"2023"},{"key":"10.1016\/j.exger.2023.112334_bb0470","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/ggi.12747","article-title":"Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resection","volume":"17","author":"Kinoshita","year":"2017","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.exger.2023.112334_bb0475","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-pharmtox-011112-140254","article-title":"Direct-acting antiviral agents for hepatitis C virus infection","volume":"53","author":"Kiser","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.exger.2023.112334_bb0480","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3390\/pharmaceutics14061213","article-title":"Promising therapeutic strategies for colorectal cancer treatment based on nanomaterials","volume":"14","author":"Krasteva","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exger.2023.112334_bb0485","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/S0142-9612(01)00381-7","article-title":"Membranes for biohybrid liver support systems\u2014investigations on hepatocyte attachment, morphology and growth","volume":"23","author":"Krasteva","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.exger.2023.112334_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1163\/1568562052843348","article-title":"Membranes for biohybrid liver support: the behaviour of C3A hepatoblastoma cells is dependent on the composition of acrylonitrile copolymers","volume":"16","author":"Krasteva","year":"2005","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.exger.2023.112334_bb0495","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7861\/clinmed.2020-0631","article-title":"Acute-on-chronic liver failure","volume":"20","author":"Kumar","year":"2020","journal-title":"Clin. Med. (Lond.)"},{"key":"10.1016\/j.exger.2023.112334_bb0500","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16193570","article-title":"Overview of the pathogenesis, genetic, and non-invasive clinical, biochemical, and scoring methods in the assessment of NAFLD","volume":"16","author":"Kupcova","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.exger.2023.112334_bb0505","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbadis.2018.01.009","article-title":"Prospects in non-invasive assessment of liver fibrosis: liquid biopsy as the future gold standard?","volume":"1864","author":"Lambrecht","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.exger.2023.112334_bb0510","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/stem.1457","article-title":"Concise review: clinical programs of stem cell therapies for liver and pancreas","volume":"31","author":"Lanzoni","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.exger.2023.112334_bb0515","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0520","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11892-019-1270-y","article-title":"Thiazolidinediones: the forgotten diabetes medications","volume":"19","author":"Lebovitz","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.exger.2023.112334_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo","volume":"3","author":"Lin","year":"2014","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.exger.2023.112334_bb0530","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.exger.2023.112334_bb0535","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1007\/s10620-019-05699-z","article-title":"Efficacy of probiotics and synbiotics in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"64","author":"Liu","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.exger.2023.112334_bb0540","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13287-022-03041-5","article-title":"Stem cells for treatment of liver fibrosis\/cirrhosis: clinical progress and therapeutic potential","volume":"13","author":"Liu","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.exger.2023.112334_bb0545","first-page":"125","article-title":"Efficacy and safety of glecaprevir\/pibrentasvir in patients with chronic HCV infection","volume":"9","author":"Liu","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0550","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1158\/1078-0432.CCR-21-4424","article-title":"Phase I\/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma","volume":"28","author":"L\u00f6ffler","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.exger.2023.112334_bb0555","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.28280","article-title":"Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis","volume":"63","author":"Lok","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.exger.2023.112334_bb0560","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/egh.11.24","article-title":"Perspectives on cellular dysfunction in nonalcoholic steatohepatitis: a case of \u2018multiorganelle failure\u2019? Proceedings of a virtual workshop on nonalcoholic steatohepatitis","volume":"5","author":"Lonardo","year":"2011","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"1463\u20131473","key":"10.1016\/j.exger.2023.112334_bb0565","article-title":"GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease","volume":"155","author":"Loomba","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exger.2023.112334_bb0570","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.29514","article-title":"The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial","volume":"67","author":"Loomba","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.exger.2023.112334_bb0575","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell."},{"key":"10.1016\/j.exger.2023.112334_bb0580","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.exger.2023.112334_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106396","article-title":"SGLT2-inhibitors are effective and safe in the elderly: the SOLD study","volume":"183","author":"Lunati","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"124","key":"10.1016\/j.exger.2023.112334_bb0590","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1152\/japplphysiol.00399.2017","article-title":"Adipose tissue and liver","volume":"1985","author":"Lundbom","year":"2018","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.exger.2023.112334_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.672564","article-title":"CRISPR\/Cas9-mediated in vivo genetic correction in a mouse model of hemophilia A","volume":"9","author":"Luo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.exger.2023.112334_bb0600","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/17425247.2018.1517746","article-title":"Delivery approaches for CRISPR\/Cas9 therapeutics in vivo: advances and challenges","volume":"15","author":"Luther","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.exger.2023.112334_bb0605","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.apsb.2019.11.007","article-title":"Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR\/Cas9: a novel model for drug transport and hyperbilirubinemia disease","volume":"10","author":"Ma","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.exger.2023.112334_bb0610","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1665-2681(19)31457-7","article-title":"Gut microbiota and nonalcoholic fatty liver disease","volume":"11","author":"Machado","year":"2012","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0615","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5170402","article-title":"Pathogenesis of nonalcoholic steatohepatitis: interactions between liver parenchymal and nonparenchymal cells","volume":"2016","author":"Magee","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.exger.2023.112334_bb0620","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6940283","article-title":"Stem cells applications in regenerative medicine and disease therapeutics","volume":"2016","author":"Mahla","year":"2016","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.exger.2023.112334_bb0625","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/ptr.6637","article-title":"Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials","volume":"34","author":"Mahmoodi","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.exger.2023.112334_bb0630","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1172\/JCI59261","article-title":"Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration","volume":"121","author":"Malato","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exger.2023.112334_bb0635","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.27131","article-title":"Epigenetics in liver disease","volume":"60","author":"Mann","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.exger.2023.112334_bb0640","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis C virus infection","volume":"3","author":"Manns","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.exger.2023.112334_bb0645","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.1840360609","article-title":"NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marrero","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.exger.2023.112334_bb0650","article-title":"Vitamin E and pioglitazone: a comprehensive systematic review of their efficacy in non-alcoholic fatty liver disease","volume":"15","author":"Mazhar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.exger.2023.112334_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041326","article-title":"Food and nutrition in the pathogenesis of liver damage","volume":"13","author":"Mega","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.exger.2023.112334_bb0660","first-page":"21","article-title":"Age, alcohol metabolism and liver disease","volume":"11","author":"Meier","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.exger.2023.112334_bb0665","first-page":"246","article-title":"Role of epigenetics in biology and human diseases","volume":"20","author":"Moosavi","year":"2016","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.exger.2023.112334_bb0670","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","article-title":"Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF","volume":"72","author":"Moreau","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0675","article-title":"The role of thiazolidinediones in the amelioration of nonalcoholic fatty liver disease: a systematic review","volume":"14","author":"Ndakotsu","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.exger.2023.112334_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154925","article-title":"Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease","volume":"126","author":"Negi","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.exger.2023.112334_bb0685","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","article-title":"Therapeutic landscape for NAFLD in 2020","volume":"158","author":"Neuschwander-Tetri","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exger.2023.112334_bb0690","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7150\/jca.7279","article-title":"Treatment for hepatocellular carcinoma in elderly patients: a literature review","volume":"4","author":"Nishikawa","year":"2013","journal-title":"J. Cancer"},{"key":"10.1016\/j.exger.2023.112334_bb0695","first-page":"545","article-title":"CRISPR-mediated genomic addition to CPS1 deficient iPSCs is insufficient to restore nitrogen homeostasis","volume":"94","author":"Nitzahn","year":"2021","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0705","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/MEG.0000000000001191","article-title":"Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?","volume":"30","author":"Oikonomou","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0710","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11605-008-0758-6","article-title":"Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more","volume":"13","author":"Oishi","year":"2009","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.exger.2023.112334_bb0715","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.31205","article-title":"Cilofexor, a nonsteroidal FXR agonist, in patients with noncirrhotic NASH: a phase 2 randomized controlled trial","volume":"72","author":"Patel","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.exger.2023.112334_bb0720","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1665-2681(19)31004-X","article-title":"Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population","volume":"12","author":"Perez-Gutierrez","year":"2013","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0725","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0039-3402033","article-title":"Aging and the biological response to liver injury","volume":"40","author":"Pinto","year":"2020","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.exger.2023.112334_bb0730","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","article-title":"ESPEN guideline on clinical nutrition in liver disease","volume":"38","author":"Plauth","year":"2019","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.exger.2023.112334_bb0735","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.2147\/IJN.S145951","article-title":"Nanoparticles for the treatment of liver fibrosis","volume":"12","author":"Poilil Surendran","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.exger.2023.112334_bb0740","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1208809","article-title":"Exploratory study of oral combination antiviral therapy for hepatitis C","volume":"368","author":"Poordad","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0745","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1200\/JCO.21.00163","article-title":"Donafenib versus sorafenib in first-line treatment of unresectable or metastatic hepatocellular carcinoma: a randomized, open-label, parallel-controlled phase II-III trial","volume":"39","author":"Qin","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.exger.2023.112334_bb0750","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113085","article-title":"Aging of liver in its different diseases","volume":"23","author":"Radonjic","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exger.2023.112334_bb0755","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/liv.15157","article-title":"Integrins as a drug target in liver fibrosis","volume":"42","author":"Rahman","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.exger.2023.112334_bb0760","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00002512-200421040-00004","article-title":"Pioglitazone is effective therapy for elderly patients with type 2 diabetes mellitus","volume":"21","author":"Rajagopalan","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.exger.2023.112334_bb0765","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archsurg.138.10.1089","article-title":"Transplantation in elderly patients","volume":"138","author":"Randall","year":"2003","journal-title":"Arch. Surg."},{"key":"10.1016\/j.exger.2023.112334_bb0770","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2021.10.018","article-title":"EDP-305 in patients with NASH: a phase II double-blind placebo-controlled dose-ranging study","volume":"76","author":"Ratziu","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0775","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.3748\/wjg.v28.i40.5818","article-title":"Management of liver diseases: current perspectives","volume":"28","author":"Ray","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042022","article-title":"Therapeutic vaccines against hepatocellular carcinoma in the immune checkpoint inhibitor era: time for neoantigens?","volume":"23","author":"Rep\u00e1raz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.exger.2023.112334_bb0785","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.exger.2023.112334_bb0790","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1038\/s41467-021-23322-6","article-title":"Author correction: murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA","volume":"12","author":"Rizvi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exger.2023.112334_bb0795","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027330","article-title":"Real-world efficacy and safety of switching to bictegravir\/emtricitabine\/tenofovir alafenamide in older people living with HIV","volume":"100","author":"Rolle","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.exger.2023.112334_bb0800","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","article-title":"Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/\u03b2-catenin pathway","volume":"10","author":"Rong","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.exger.2023.112334_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071634","article-title":"Safety and efficacy of transarterial chemoembolization in elderly patients with intermediate hepatocellular carcinoma","volume":"14","author":"Roth","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.exger.2023.112334_bb0810","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/hep.32022","article-title":"Modeling phenotypic heterogeneity of glycogen storage disease type 1a liver disease in mice by somatic CRISPR\/CRISPR-associated protein 9-mediated gene editing","volume":"74","author":"Rutten","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.exger.2023.112334_bb0815","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13679-017-0262-y","article-title":"Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over","volume":"6","author":"Ryan","year":"2017","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.exger.2023.112334_bb0820","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.30664","article-title":"The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials","volume":"70","author":"Sanyal","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.exger.2023.112334_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114244","article-title":"Targeting PI3K\/AKT signaling pathway in obesity","volume":"159","author":"Savova","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exger.2023.112334_bb0830","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12877-017-0574-5","article-title":"Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing","volume":"17","author":"Schlender","year":"2017","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.exger.2023.112334_bb0835","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.exger.2005.06.009","article-title":"Age-related changes in liver structure and function: implications for disease\u202f?","volume":"40","author":"Schmucker","year":"2005","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.exger.2023.112334_bb0840","article-title":"MAFLD\/NAFLD biopsy-free scoring systems for hepatic steatosis, NASH, and fibrosis diagnosis","volume":"8","author":"Segura-Azuara","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0845","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1515\/BC.2006.047","article-title":"Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress","volume":"387","author":"Seitz","year":"2006","journal-title":"Biol. Chem."},{"key":"10.1016\/j.exger.2023.112334_bb0850","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/oby.2009.126","article-title":"Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults","volume":"17","author":"Shah","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.exger.2023.112334_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.104784","article-title":"CRISPR\/Cas9 gene editing: a new hope for transthyretin amyloidosis treatment","volume":"83","author":"Shahzad","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.exger.2023.112334_bb0860","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1665-2681(19)31515-7","article-title":"Do older patients utilize excess health care resources after liver transplantation?","volume":"10","author":"Shankar","year":"2011","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb0865","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2147\/JHC.S383922","article-title":"Expert insights on current treatments for hepatocellular carcinoma: clinical and molecular approaches and bottlenecks to progress","volume":"9","author":"Shannon","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.exger.2023.112334_bb0870","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00268-009-0122-3","article-title":"Early outcome following hepatic resection in patients older than 80 years of age","volume":"33","author":"Shirabe","year":"2009","journal-title":"World J. Surg."},{"key":"10.1016\/j.exger.2023.112334_bb0875","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/thy.2018.0664","article-title":"Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists","volume":"29","author":"Sinha","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.exger.2023.112334_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105484","article-title":"Epigenetics in NAFLD\/NASH: targets and therapy","volume":"167","author":"Sodum","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exger.2023.112334_bb0885","article-title":"Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: delving into the potential benefits of cardiorenal protection beyond the treatment of Type-2 diabetes mellitus","volume":"13","author":"Srinivas","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.exger.2023.112334_bb0890","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fmed.2020.00544","article-title":"Bile acids and FXR: novel targets for liver diseases","volume":"7","author":"Stofan","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109735","article-title":"A review on epidermal growth factor receptor\u2019s role in breast and non-small cell lung cancer","volume":"351","author":"Subramaniyan","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.exger.2023.112334_bb0900","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/1096-9071(200012)62:4<456::AID-JMV10>3.0.CO;2-3","article-title":"Hepatitis B virus infection among residents of a nursing home for the elderly: seroepidemiological study and molecular evolutionary analysis","volume":"62","author":"Sugauchi","year":"2000","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.exger.2023.112334_bb0905","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exger.2023.112334_bb0910","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12951-021-00843-2","article-title":"Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors","volume":"19","author":"Sun","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.exger.2023.112334_bb0915","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.3748\/wjg.v19.i46.8459","article-title":"Liver physiology and liver diseases in the elderly","volume":"19","author":"Tajiri","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb0920","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1872-034X.2010.00713.x","article-title":"Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients","volume":"40","author":"Takahashi","year":"2010","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.exger.2023.112334_bb0925","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.3748\/wjg.v21.i13.3777","article-title":"Current pharmacological therapies for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"21","author":"Takahashi","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb0930","doi-asserted-by":"crossref","first-page":"25881","DOI":"10.3390\/ijms161025881","article-title":"Heat killed Lactobacillus reuteri GMNL-263 reduces fibrosis effects on the liver and heart in high fat diet-hamsters via TGF-beta suppression","volume":"16","author":"Ting","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exger.2023.112334_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/nu10050649","article-title":"Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors","volume":"10","author":"Tiwari-Heckler","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.exger.2023.112334_bb0940","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1535370215596383","article-title":"Light therapy modulates serotonin levels and blood flow in women with headache. A preliminary study","volume":"241","author":"Tomaz de Magalhaes","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.exger.2023.112334_bb0945","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.exger.2023.112334_bb0950","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ymthe.2018.12.012","article-title":"Delivery of mRNA therapeutics for the treatment of hepatic diseases","volume":"27","author":"Trepotec","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exger.2023.112334_bb0955","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041345","article-title":"Effects of low-carbohydrate versus Mediterranean diets on weight loss, glucose metabolism, insulin kinetics and \u03b2-cell function in morbidly obese individuals","volume":"13","author":"Tric\u00f2","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.exger.2023.112334_bb0960","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.surg.2009.10.054","article-title":"Outcome of repeat hepatectomy in patients with hepatocellular carcinoma aged 75 years and older","volume":"147","author":"Tsujita","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.exger.2023.112334_bb0965","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2015.02.004","article-title":"Anti-inflammatory effect of resveratrol in old mice liver","volume":"64","author":"Tung","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.exger.2023.112334_bb0970","series-title":"Our World Is Growing Older: UN DESA Releases New Report on Ageing","author":"United Nations, D.o.E.a.S.A","year":"2019"},{"key":"10.1016\/j.exger.2023.112334_bb0975","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211034300","article-title":"Therapeutic approaches for non-alcoholic steatohepatitis","volume":"12","author":"Van Gaal","year":"2021","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.exger.2023.112334_bb0980","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.exger.2023.112334_bb0985","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/flgastro-2018-101104","article-title":"Recent advances in alcoholic hepatitis","volume":"11","author":"Veryan","year":"2020","journal-title":"Frontline Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb0990","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2147\/VHRM.S4053","article-title":"Safety and efficacy of rosiglitazone in the elderly diabetic patient","volume":"5","author":"Viljoen","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.exger.2023.112334_bb0995","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJMoa1008234","article-title":"Weight loss, exercise, or both and physical function in obese older adults","volume":"364","author":"Villareal","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exger.2023.112334_bb1000","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jnutbio.2012.01.014","article-title":"Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model","volume":"24","author":"Wagnerberger","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.exger.2023.112334_bb1005","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.metabol.2016.01.011","article-title":"Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity","volume":"65","author":"Walle","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.exger.2023.112334_bb1010","article-title":"Role of exosomes in chronic liver disease development and their potential clinical applications","volume":"2022","author":"Wang","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.exger.2023.112334_bb1015","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41392-022-01211-8","article-title":"Epigenetic regulation of aging: implications for interventions of aging and diseases","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.exger.2023.112334_bb1020","article-title":"Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exger.2023.112334_bb1025","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/onco.13901","article-title":"Neoadjuvant treatment with angiogenesis-inhibitor dovitinib prior to local therapy in hepatocellular carcinoma: a phase II study","volume":"26","author":"Woei","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.exger.2023.112334_bb1030","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3350\/cmh.2019.0044n","article-title":"Entecavir+tenofovir vs. lamivudine\/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response","volume":"26","author":"Woo","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb1035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41392-022-01104-w","article-title":"Dietary regulation in health and disease","volume":"7","author":"Wu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.exger.2023.112334_bb1040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002617","article-title":"Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation","volume":"8","author":"Wu","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.exger.2023.112334_bb1045","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.3748\/wjg.v27.i34.5753","article-title":"Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease","volume":"27","author":"Wu","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exger.2023.112334_bb1050","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2013.12.003","article-title":"Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice","volume":"60","author":"Xiong","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb1055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4274\/tjps.75047","article-title":"Histone deacetylase inhibitors: a prospect in drug discovery","volume":"16","author":"Yadav","year":"2019","journal-title":"Turk. J. Pharm. Sci."},{"key":"10.1016\/j.exger.2023.112334_bb1060","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41401-022-00860-3","article-title":"Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis","volume":"43","author":"Yang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.exger.2023.112334_bb1065","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/liv.14916","article-title":"Effects of lifestyle interventions on epigenetic signatures of liver fat: central randomized controlled trial","volume":"41","author":"Yaskolka Meir","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.exger.2023.112334_bb1070","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.4564","article-title":"Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial","volume":"6","author":"Yau","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.exger.2023.112334_bb1075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.exger.2023.112334_bb1080","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.909455","article-title":"The burden of liver cirrhosis in mortality: results from the global burden of disease study","volume":"10","author":"Ye","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.exger.2023.112334_bb1085","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.exger.2023.112334_bb1090","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nbt.2884","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Yin","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.exger.2023.112334_bb1095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease \u2013 a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb1100","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.exger.2023.112334_bb1105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13098-020-00543-1","article-title":"Evaluation of efficacy and safety of DPP-4 inhibitors for Chinese elderly patients with type 2 diabetes mellitus","volume":"12","author":"Yu","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.exger.2023.112334_bb1110","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091256","article-title":"Dietary patterns influence target gene expression through emerging epigenetic mechanisms in nonalcoholic fatty liver disease","volume":"9","author":"Zaiou","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.exger.2023.112334_bb1115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13287-015-0106-1","article-title":"The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency","volume":"6","author":"Zekri","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.exger.2023.112334_bb1120","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00007890-199808270-00015","article-title":"Age and liver transplantation: a report of the liver transplantation database","volume":"66","author":"Zetterman","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.exger.2023.112334_bb1125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ymthe.2016.10.004","article-title":"A proof-of-concept for epigenetic therapy of tissue fibrosis: inhibition of liver fibrosis progression by 3-deazaneplanocin A","volume":"25","author":"Zeybel","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exger.2023.112334_bb1130","article-title":"The application of induced pluripotent stem cells against liver diseases: an update and a review","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.exger.2023.112334_bb1135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12951-023-01788-4","article-title":"Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.exger.2023.112334_bb1140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1743-422X-7-211","article-title":"Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review","volume":"7","author":"Zhao","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.exger.2023.112334_bb1145","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12381","article-title":"Protective effect of carvacrol on liver injury in type 2 diabetic db\/db mice","volume":"24","author":"Zhao","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.exger.2023.112334_bb1150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nutres.2006.04.001","article-title":"Nutritional support of pediatric patients with cancer consuming an enteral formula with fructooligosaccharides","volume":"26","author":"Zheng","year":"2006","journal-title":"Nutr. Res."},{"key":"10.1016\/j.exger.2023.112334_bb1155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1470-2045(18)30937-9","article-title":"Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased \u03b1-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Zhu","year":"2019","journal-title":"Lancet Oncol."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556523002553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556523002553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:17:13Z","timestamp":1778692633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556523002553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":229,"alternative-id":["S0531556523002553"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2023.112334","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Old age as a risk factor for liver diseases: Modern therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2023.112334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112334"}}